The mutation NTRK3L449F was observed in a patient with T-cell ALL and located in the transmembrane domain.10 On the other hand, Trk fusions are the most frequent genetic alteration connected to carcinogenic activity in Trk-driven liquid tumors. This evidence concerns the gene NTRK1 and T-cell acute lymphoblastic leukemia.